PATENT CLAIM ANALYSIS

Application Number: 16279576
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["435", "455000"]

Abstract:
The present disclosure provides a method of restoring or enhancing visual function in an individual, the method comprising administering to the individual a nucleic acid comprising a nucleotide sequence encoding one or more of a medium wavelength cone opsin (MW-opsin), a long wavelength cone opsin (LW-opsin), and a short wavelength cone opsin (SW-opsin). One or more of the MW-opsin, LW-opsin, and SW-opsin is expressed in a retinal cell in the individual, thereby restoring or enhancing visual function.

Claim (Index 74):
The method of  claim 55 , wherein the individual has an ocular disease selected from retinitis pigmentosa, macular degeneration, retinoschisis, and Leber's Congenital Amaurosis, and diabetic retinopathy.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 99.0
- Lexical Diversity: 1.97826
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15127757', '14555048', '14911405', '15559315', '15097925']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5564168420105395
- 35 USC 102 Novelty (BERT): 0.501292883138342
- Combined Prediction Score: 0.5509044461233198
- Mean Citation Score: 245.468932
- Max Citation Score: 254.71846
- Similarity Product: 181.47253412349224

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test